via forbes.com
While drug companies were great at inventing new medicines, they were often in over their heads when it came to analyzing mountains of data from clinical trials. "It became apparent that there was the possibility of making the pharmaceuticals sector more efficient," explains Gillings, now 66.
No comments:
Post a Comment